Cartalax news and clinical trials
Also known as: AED · AED peptide · Ala-Glu-Asp · T-31 · Kartalax · Alanyl-glutamyl-aspartic acid · Cartilage bioregulator
Updated 20 sources
2 new studies in the last 12 months, newest first: trial registrations and results, PubMed papers, FDA actions and press coverage that name Cartalax. Each line links to the primary source.
October 2026
- StudyPubMedEpitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence (opens PubMed)
A narrative review of Epitalon and Epithalamin found that while Epitalon is biologically active in modulating aging markers in preclinical studies, it remains clinically unproven in humans. No adequately powered randomized trial has established therapeutic efficacy.
International journal of molecular sciencesReviewPMID 42884164
September 2026
- StudyPubMedIdentification of a novel conserved B-cell epitope in the glycoprotein of rabies virus (opens PubMed)
Researchers identified a novel, highly conserved linear B-cell epitope on the rabies virus glycoprotein using monoclonal antibodies. This finding provides a potential molecular target for the design of next-generation epitope-based vaccines and diagnostic tools.
Medical microbiology and immunologyPMID 42709216
Searched as: Cartalax, AED peptide, Ala-Glu-Asp, Kartalax, Alanyl-glutamyl-aspartic acid, Cartilage bioregulator. Summaries are one or two sentences, published only when every number in them appears in the source record. A tracker, not medical advice.